Higginbotham EJ: Interview with Eve J. Higginbotham, MD. JAMA Ophthalmology 131 (1): 96-97,2013.
Me'Ja Day: Spotlight, Laser Trabeculoplasty: A Patient-Centered View in Glaucoma, Second Edition Elsevier : 2013.
Higginbotham: The Word of the Day in Healthcare: Accountability. Glaucoma Today : 2012.
Higginbotham: Glaucoma Screenings and Treatment Under Siege. When Will the Evidence be Enough? Glaucoma Today : 2012.
Higginbotham: The Physician Workforce Revisited: What are the Implications for Ophthalmology? Arch Ophthalmol 130 : 648-649,2012.
Making the Case for Hastening the Progress towards Health Equity. Commentary, Institute of Medicine, Washington DC : 2012.
Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK: Ocular Hypertension Treatment Study Group. Delaying Treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol 128 (3): 276-87,2010.
Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK: United States Fixed-Combination Study Group. Fixed combination of latanoprost and timolol vs. individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study. Arch Ophthalmol 2 : 165-72,2010.
Considerations in glaucoma therapy; fixed combinations versus their component medications. Clin Ophthalmolol 4 : 1-9,2010.
Assessing the status of ophthalmic education 100 years after the Flexner Report. Arch Ophthalmol 128 (12): 1600-01,2010.